Quinazoline based EGFR inhibitors containing a zinc binding moiety

Details for Australian Patent Application No. 2007296746 (hide)

Owner Curis, Inc.

Inventors Zhai, Haixiao; Cai, Xiong; Gould, Stephen; Qian, Changgeng

Agent Pizzeys

Pub. Number AU-B-2007296746

PCT Pub. Number WO2008/033749

Priority 60/843,644 11.09.06 US; 60/895,873 20.03.07 US

Filing date 10 September 2007

Wipo publication date 20 March 2008

Acceptance publication date 5 July 2012

International Classifications

C07D 239/88 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/04 Antineoplastic agents

C07D 239/93 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/94 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/033749 Priority application(s): WO2008/033749

5 July 2012 Application Accepted

  Published as AU-B-2007296746

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296750-Apparatus, method and system for restraining an object in a vehicle

2007296745-Quinazoline based EGFR inhibitors